
Research

Scientists at the German Cancer Research Center (DKFZ) have shown in an international eye-tracking study that dermatologists not only improve their diagnostic accuracy by using explainable artificial intelligence, but also show significantly less fatigue when assessing challenging cases. The researchers were able to demonstrate this by measuring a reduction in cognitive stress indicators. In a […]
read more
Excellence Strategy: HITS researchers successful with two clusters on astrophysics and life sciences
How do stellar explosions or the evolution of galaxies influence our universe today? How can synthetic biology and specially designed cells aid in the protection of our immune system against infections and cancer? Tackling these research questions from different disciplines is the endeavor of two projects that have been selected as Clusters of Excellence in the […]
read more
Universität Heidelberg Successful With Three Applications for Clusters of Excellence
Funding for research projects at the highest level internationally In the context of the Excellence Strategy of the Federal and State Governments, Heidelberg University has been successful with three applications in the Cluster of Excellence funding line. According to the decision on selection announced today (Thursday 22 May 2025), not only will the existing cluster […]
read more
How the Epstein-Barr virus promotes its spread in the body
Many people are infected with the Epstein-Barr virus (EBV), and most are unaware of it. However, EBV can sometimes cause cancer, and this pathogen also appears to play an important role in multiple sclerosis and other autoimmune diseases. Researchers at the German Cancer Research Center (DKFZ) and the Kidney Center at Heidelberg University Hospital have […]
read more
How aging changes the blood system in humans and mice
The reservoir of blood stem cells shrinks with age. It becomes increasingly dominated by stem cells that produce immune cells associated with chronic inflammation. Almost all of the 60-year-olds studied show this change. Researchers from the Centre for Genomic Regulation and the Institute for Research in Biomedicine, both in Barcelona, and the German Cancer Research […]
read more
Childhood brain tumors develop early in highly specialized nerve cells
Medulloblastomas, childhood brain tumors in children, are thought to develop between the first trimester of pregnancy and the end of the first year of life. Researchers at the Hopp Children’s Cancer Center Heidelberg (KiTZ), the German Cancer Research Center (DKFZ) and Heidelberg University Hospital (UKHD) have now published their findings in the journal Nature. They […]
read more
3D bioprinting: NMI, TU Darmstadt and Black Drop develop improved bioink
Joint press release by the NMI and the Technical University of Darmstadt (How) can we 3D print tissues that mimic the complex anatomy of natural body tissue as closely as possible? 3D bioprinting is a great hope in the field of regenerative medicine to produce miniaturized tissues and organ precursors with biological functionality. Today, however, […]
read more
Pancreatic Cancer: Interactions between Neurons and Tumor
Nikon Imaging Center at Heidelberg University achieves three-dimensional reconstruction of nerve network in the pancreas tissue Pancreatic cancer is fueled by connections to the nervous system, as was shown by scientists from the German Cancer Research Center (DKFZ) and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM). In a recent study, they […]
read more
Blenrep (belantamab mafodotin) combinations approved by UK MHRA in relapsed/refractory multiple myeloma
GSK plc (LSE/NYSE: GSK) today announced the authorisation of Blenrep by the Medicines and Healthcare products Regulatory Agency (MHRA). In the UK, Blenrep is approved for the treatment of adults with multiple myeloma in combination with bortezomib plus dexamethasone (BVd) in patients who have received at least one prior therapy, and in combination with pomalidomide plus dexamethasone (BPd) in […]
read more